Get Quote
๐ŸŒ Trusted Across African Pharmaceutical Markets

DPP-260 Blister Machine for African Pharma Manufacturing

WHO GMP, NAFDAC, EDA, PPB, SAHPRA compliant automatic blister packing machine for African pharmaceutical manufacturers in Nigeria, Egypt, Kenya, South Africa, Ethiopia, Morocco, Algeria, Ghana. 30+ DPP-260 machines installed across the continent supporting AfCFTA pharmaceutical localization.

WHO GMP & PIC/S
AfCFTA Trade Compliant
8 Country Regulatory
30+ Africa Installations
DPP-260 Blister Packing Machine for African Pharmaceutical Manufacturers
30+
DPP-260 Machines
Installed in Africa
8
African Countries
HIJ Serves
18-26
Weeks Order to
Production-Ready
WHO PQ
Compliant for
UNICEF/GAVI Tenders

DPP-260 Across All 5 African Regions

HIJ DPP-260 supports pharmaceutical manufacturing localization across West, East, North, Southern, and Central Africa under African Continental Free Trade Area (AfCFTA) framework.

๐ŸŒ

West Africa

12+ DPP-260 Installations

ECOWAS pharma manufacturers serving 400M+ population. Major hubs: Lagos (Nigeria), Tema (Ghana), Abidjan (Ivory Coast), Dakar (Senegal).

  • Nigeria: NAFDAC compliance, 8+ installations
  • Ghana: FDA Ghana, ECOWAS market
  • Ivory Coast: ANSP regulatory, francophone
  • Senegal: ARP, Maghreb-W. Africa hub
๐ŸŒ

East Africa

8+ DPP-260 Installations

EAC pharmaceutical manufacturing hub serving 300M+ population. Kenya leads regional pharma exports to neighboring markets and African Union.

  • Kenya: PPB compliance, 4+ installations
  • Ethiopia: EFDA, large domestic market
  • Uganda: NDA, EAC pharma hub
  • Tanzania: TMDA, growing market
๐ŸŒ

North Africa (Maghreb)

6+ DPP-260 Installations

Major MENA pharma exporters serving 200M+ population. Egypt and Morocco lead with strong GMP infrastructure aligned with EU standards.

  • Egypt: EDA compliance, 3+ installations
  • Morocco: DMP, EU-aligned pharma
  • Algeria: LNCPP, large generic market
  • Tunisia: DPM, MENA exports
๐ŸŒ

Southern Africa

4+ DPP-260 Installations

SADC pharma cluster led by South Africa with PIC/S GMP membership. Strong regulatory infrastructure and pharmaceutical export to neighboring markets.

  • South Africa: SAHPRA + PIC/S, 3+ installs
  • Zambia: ZAMRA, growing market
  • Mozambique: ANARME, SADC exports
  • Botswana: BOMRA, regional supplier

DPP-260 Across 8 Major African Pharmaceutical Markets

Country-specific guide for HIJ DPP-260 deployment in African pharmaceutical manufacturing โ€” regulatory compliance, ports, and market focus.

๐Ÿ‡ณ๐Ÿ‡ฌ

Nigeria

8+ DPP-260 Installed
RegulatorNAFDAC + WHO GMP
PortsLagos (Apapa, Tin Can)
Sea Transit28-32 days
Import Duty5-10% (capital goods)
Market Size220M+ population
Pharma HubsLagos, Abuja, Onitsha
๐Ÿ‡ช๐Ÿ‡ฌ

Egypt

3+ DPP-260 Installed
RegulatorEDA + WHO GMP
PortsAlexandria, Damietta
Sea Transit18-22 days (via Suez)
Import Duty10-20% + 14% VAT
Market Size100M+ population
Pharma Hubs6th October City, Sadat City
๐Ÿ‡ฐ๐Ÿ‡ช

Kenya

4+ DPP-260 Installed
RegulatorPPB + WHO GMP
PortsMombasa
Sea Transit21-25 days
Import Duty0% (capital goods exempt)
Market Size55M + EAC region
Pharma HubsNairobi, Athi River
๐Ÿ‡ฟ๐Ÿ‡ฆ

South Africa

3+ DPP-260 Installed
RegulatorSAHPRA + PIC/S GMP
PortsDurban, Cape Town
Sea Transit30-35 days
Import Duty0-5% (SADC reduced)
Market Size60M + SADC region
Pharma HubsGauteng, Western Cape
๐Ÿ‡ช๐Ÿ‡น

Ethiopia

2+ DPP-260 Installed
RegulatorEFDA + WHO GMP
PortsDjibouti (transit)
Sea Transit25-30 days
Import Duty5-10% (pharma incentives)
Market Size120M+ population
Pharma HubsAddis Ababa, Kilinto
๐Ÿ‡ฒ๐Ÿ‡ฆ

Morocco

2+ DPP-260 Installed
RegulatorDMP + WHO GMP
PortsCasablanca, Tangier
Sea Transit22-26 days
Import Duty2.5-10%
Market Size37M + Maghreb
Pharma HubsCasablanca, Rabat
๐Ÿ‡ฉ๐Ÿ‡ฟ

Algeria

2+ DPP-260 Installed
RegulatorLNCPP + WHO GMP
PortsAlgiers, Oran
Sea Transit22-26 days
Import Duty5-15%
Market Size45M+ population
Pharma HubsAlgiers, Constantine
๐Ÿ‡ฌ๐Ÿ‡ญ

Ghana

2+ DPP-260 Installed
RegulatorFDA Ghana + WHO GMP
PortsTema, Takoradi
Sea Transit28-32 days
Import Duty0-10% (ECOWAS)
Market Size33M + ECOWAS region
Pharma HubsAccra, Tema

DPP-260 Compliant with All African Regulators

DPP-260 validation documentation and engineering meet pharmaceutical regulatory requirements across major African and global pharmaceutical authorities.

๐Ÿ‡ณ๐Ÿ‡ฌ

Nigeria NAFDAC

National Agency for Food and Drug Administration

๐Ÿ‡ช๐Ÿ‡ฌ

Egypt EDA

Egyptian Drug Authority

๐Ÿ‡ฐ๐Ÿ‡ช

Kenya PPB

Pharmacy and Poisons Board

๐Ÿ‡ฟ๐Ÿ‡ฆ

SA SAHPRA

South African Health Products Regulatory

๐Ÿ‡ช๐Ÿ‡น

Ethiopia EFDA

Ethiopian Food and Drug Authority

๐Ÿ‡ฒ๐Ÿ‡ฆ

Morocco DMP

Direction du Mรฉdicament et de la Pharmacie

๐Ÿ‡ฉ๐Ÿ‡ฟ

Algeria LNCPP

Laboratoire National de Contrรดle

๐Ÿ‡ฌ๐Ÿ‡ญ

Ghana FDA

Food and Drugs Authority Ghana

๐ŸŒ

WHO GMP

World Health Organization TRS 961

๐Ÿ‡ช๐Ÿ‡บ

PIC/S GMP

Pharmaceutical Inspection Co-operation

๐ŸŒ

WHO PQ

WHO Prequalification (UNICEF, GAVI)

๐Ÿ†Ž

AfCFTA

African Continental Free Trade Area

DPP-260 Shipping & Duty by African Country

Country-by-country breakdown of sea shipping time, import duty, and CIF cost from Wenzhou (China) to African pharmaceutical destinations.

Country / Port Sea Transit Import Duty Sea Freight (USD)
๐Ÿ‡ณ๐Ÿ‡ฌNigeria (Lagos)28-32 days5-10%$3,200-4,200
๐Ÿ‡ช๐Ÿ‡ฌEgypt (Alexandria)18-22 days10-20% + 14% VAT$2,500-3,500
๐Ÿ‡ฐ๐Ÿ‡ชKenya (Mombasa)21-25 days0% (capital goods)$2,800-3,800
๐Ÿ‡ฟ๐Ÿ‡ฆSouth Africa (Durban)30-35 days0-5% (SADC reduced)$3,200-4,500
๐Ÿ‡ช๐Ÿ‡นEthiopia (via Djibouti)25-30 days5-10% (pharma incentives)$3,000-4,000
๐Ÿ‡ฒ๐Ÿ‡ฆMorocco (Casablanca)22-26 days2.5-10%$2,800-3,800
๐Ÿ‡ฉ๐Ÿ‡ฟAlgeria (Algiers)22-26 days5-15%$2,800-3,800
๐Ÿ‡ฌ๐Ÿ‡ญGhana (Tema)28-32 days0-10% (ECOWAS)$3,000-4,000
๐Ÿ‡จ๐Ÿ‡ฎIvory Coast (Abidjan)30-34 days0-10% (ECOWAS)$3,200-4,200
๐Ÿ‡ธ๐Ÿ‡ณSenegal (Dakar)32-36 days0-10% (ECOWAS)$3,200-4,200
๐Ÿ‡น๐Ÿ‡ฟTanzania (Dar es Salaam)23-27 days0% (capital goods)$2,800-3,800
๐Ÿ‡บ๐Ÿ‡ฌUganda (via Mombasa)25-30 days0% (capital goods)$3,000-4,000
๐Ÿ‡น๐Ÿ‡ณTunisia (Tunis)22-26 days5-15%$2,800-3,800
๐Ÿ‡ฒ๐Ÿ‡ฟMozambique (Beira)32-36 days0-5% (SADC)$3,500-4,500

* Duty rates indicative. Final duty depends on country-specific exemptions, capital goods classifications, and pharmaceutical industry incentive schemes. Many African countries provide 0% duty for pharma machinery under WHO essential medicines and government health programs.

DPP-260 China-to-Africa Import Timeline

Complete timeline from order placement to commissioned & validated machine at your African pharmaceutical factory.

1
Week 1-2

Order & Engineering

URS finalization, contract signing, 30% advance, engineering design.

2
Week 3-14

Manufacturing & FAT

Wenzhou manufacturing, FAT, video verification, balance payment.

3
Week 15-19

Sea Shipment

FCL container Wenzhou โ†’ African port (3-5 weeks varies by destination).

4
Week 20-22

Customs & Inland

Customs clearance, duty payment, inland transport to factory site.

5
Week 23-26

Install & SAT

HIJ engineer on-site installation, IQ/OQ commissioning, training.

DPP-260 Applications in African Pharmaceutical Manufacturing

Trusted by African pharmaceutical manufacturers serving domestic markets and supporting WHO essential medicines programs across the continent.

๐ŸŒ Generic Drug Production

DPP-260 widely deployed by African generic pharma manufacturers producing affordable medicines for domestic and regional markets. Critical for African pharmaceutical localization under AfCFTA framework, reducing import dependency from outside the continent.

Paracetamol Antibiotics Antimalarials Anti-TB Drugs ART/HIV Drugs

๐Ÿ’Š WHO Essential Medicines

DPP-260 supports African manufacturers producing WHO Essential Medicines List (EML) drugs. WHO Prequalification (PQ) compliance enables export to UNICEF, GAVI Alliance, Global Fund, and African Union procurement programs serving millions across Africa.

WHO PQ Compliant UNICEF Tenders Global Fund GAVI Alliance

๐ŸฆŸ Antimalarial Production

African pharmaceutical manufacturers use DPP-260 for high-volume antimalarial drug packaging โ€” artemisinin-based combination therapies (ACTs) including artemether-lumefantrine, artesunate-amodiaquine. Critical for malaria-endemic regions across Sub-Saharan Africa.

ACT Antimalarials Artemether-Lumefantrine Artesunate Combinations

๐ŸŒก๏ธ Tropical Climate Adapted

DPP-260 produces blister packaging optimized for tropical African climate (ICH Zone IVa/IVb conditions: 30ยฐC/65-75% RH). PVDC-coated PVC and Alu-Alu cold form options provide enhanced moisture barrier for hot, humid African market conditions.

ICH Zone IV PVDC Barrier Alu-Alu Cold Form Tropical Stability

Frequently Asked Questions โ€” African Pharma Buyers

Common questions from African pharmaceutical procurement teams importing DPP-260 blister machines.

What is the price of DPP-260 blister machine in Africa?
DPP-260 FOB Wenzhou price ranges USD 45,000-120,000. CIF to major African ports adds USD 2,500-4,500 sea freight depending on destination + 0.5% insurance. Import duties vary: Nigeria 5-10%, Egypt 10-20% (with VAT 14%), Kenya 0% (capital goods exemption), South Africa 0-5%, Ethiopia 5-10%, Morocco 2.5-10%. Total CIF cost typically USD 50,000-140,000. WHO PQ exemptions and government health programs may waive duties.
Does DPP-260 meet African pharmaceutical regulatory requirements?
Yes. DPP-260 complies with WHO GMP TRS 961, cGMP 21 CFR, CE, and African Medicines Agency (AMA) framework. Specific country compliance: Nigeria NAFDAC, Egypt EDA, Kenya PPB, South Africa SAHPRA, Ethiopia EFDA, Morocco DMP. Validation documentation accepted by all major African regulators including DQ/IQ/OQ/PQ protocols, FAT/SAT records, and material certificates.
How long is delivery from China to African pharma factories?
Total time from order to commissioning: 18-26 weeks. Manufacturing 12-16 weeks + sea shipment Wenzhou-to-Africa 3-5 weeks (West Africa: 28-35 days, East Africa: 21-28 days, North Africa via Suez: 18-25 days, South Africa: 30-40 days) + customs clearance 5-10 days + inland transport 3-7 days + installation & commissioning 1 week. HIJ provides complete export documentation including Form A, COO, and packing list for African customs.
Which African ports does HIJ deliver to?
HIJ ships DPP-260 to all major African ports: Lagos (Apapa/Tin Can Island, Nigeria), Tema (Ghana), Abidjan (Ivory Coast), Dakar (Senegal), Alexandria/Damietta (Egypt), Mombasa (Kenya), Dar es Salaam (Tanzania), Djibouti (serves Ethiopia), Casablanca (Morocco), Algiers (Algeria), Tunis (Tunisia), Durban/Cape Town (South Africa), Beira/Maputo (Mozambique), Luanda (Angola). Sea shipment via FCL container.
Does HIJ provide on-site service in Africa?
Yes. HIJ engineers travel on-site to African pharmaceutical facilities for installation, IQ/OQ commissioning, and operator training. Standard service: 7-10 days on-site. HIJ has completed 30+ installations across Africa including Nigeria, Egypt, Kenya, South Africa, Ethiopia, Ghana, Morocco, and Algeria. Visa-on-arrival or e-visa available for HIJ engineers traveling to most African countries. English/French communication; Arabic for North Africa coordinated.
What is DPP-260's role in African pharmaceutical localization?
DPP-260 supports African pharmaceutical manufacturing localization initiatives across the continent. African Union's Pharmaceutical Manufacturing Plan for Africa (PMPA) and African Continental Free Trade Area (AfCFTA) drive local pharma production. DPP-260 enables African manufacturers to produce affordable generic drugs locally for: WHO essential medicines list, anti-malarial drugs, anti-tuberculosis treatments, antiretroviral therapy (ART), and maternal/child health medicines. WHO Prequalification compliance enables export to UNICEF, GAVI, and Global Fund procurement programs.
Is DPP-260 suitable for Nigerian NAFDAC compliance?
Yes. DPP-260 meets Nigerian NAFDAC (National Agency for Food and Drug Administration and Control) requirements through WHO GMP compliance and complete validation documentation. NAFDAC GMP inspectors accept DPP-260 documentation including DQ/IQ/OQ/PQ protocols. HIJ has supplied DPP-260 to Nigerian pharmaceutical manufacturers in Lagos, Abuja, and Onitsha clusters. Nigeria's growing pharma manufacturing sector benefits from local production reducing import dependency.
What about Egypt EDA compliance for pharma machinery?
DPP-260 complies with Egyptian EDA (Egyptian Drug Authority, formerly CAPA) requirements through WHO GMP framework. Egypt is a major North African pharma hub with significant export to MENA markets. EDA inspectors accept HIJ validation documentation. HIJ has installed DPP-260 in Egyptian pharma manufacturers in 6th of October City, Sadat City, and Borg El Arab industrial zones serving Egypt's 100M domestic market and MENA exports.
Does DPP-260 meet South African SAHPRA standards?
Yes. DPP-260 meets South African SAHPRA (South African Health Products Regulatory Authority) requirements through WHO GMP and PIC/S GMP compliance โ€” South Africa is a PIC/S member country. SAHPRA inspectors accept HIJ validation documentation including 21 CFR Part 11 audit trail and EU GMP Annex 15 compliance. South African pharma manufacturers in Gauteng, Western Cape, and KwaZulu-Natal use DPP-260 for SADC regional exports.
What payment terms does HIJ accept for African buyers?
HIJ accepts payment in USD via T/T (Telegraphic Transfer) or L/C (Letter of Credit) against African buyer accounts. Standard payment terms: 30% advance + 70% before shipment, or 30% advance + 70% L/C at sight. Payment from African buyers is straightforward through major African banks supporting USD remittance under capital goods import provisions. For government tenders and World Bank/AfDB funded projects, HIJ accepts L/C terms aligned with multilateral agency requirements.
Can DPP-260 qualify for WHO Prequalification (PQ) supply tenders?
Yes. DPP-260 enables African manufacturers to produce WHO Prequalified pharmaceutical products. HIJ machines are installed at WHO-PQ-certified pharmaceutical manufacturers producing essential medicines for global health programs. WHO PQ compliance is essential for supplying UNICEF, GAVI Alliance, Global Fund, Stop TB Partnership, and African Union procurement tenders worth billions of dollars annually.
Does HIJ support government pharma manufacturing programs in Africa?
Yes. HIJ has supplied DPP-260 to government-backed pharmaceutical manufacturing programs across Africa including Nigeria's pharmaceutical localization initiative, Ethiopia's Kilinto Pharmaceutical Industrial Park, Kenya's Local Pharmaceutical Manufacturing program, and Egypt's pharmaceutical industrial zones. HIJ accepts payment terms aligned with African Development Bank (AfDB), World Bank, and bilateral development finance institutions funding pharma localization.

Ready to Import DPP-260 to Your African Pharma Factory?

Get a country-specific CIF quote with import duty calculation within 24 hours. HIJ engineers will recommend optimal configuration and complete import documentation for African customs. 30+ African pharma factories trust HIJ.

About This Page: The DPP-260 automatic blister packing machine is manufactured by HIJ Machinery (Wenzhou), a Chinese pharmaceutical packaging machinery company. This page provides African pharmaceutical procurement teams with comprehensive information including USD/local pricing, African regulatory compliance (NAFDAC Nigeria, EDA Egypt, PPB Kenya, SAHPRA South Africa, EFDA Ethiopia, DMP Morocco, LNCPP Algeria, FDA Ghana), customs duty structure, port logistics, and country-specific delivery options across all 5 African regions.

African Compliance: DPP-260 complies with WHO GMP TRS 961 Annex 6, African Medicines Agency (AMA) framework, PIC/S GMP (Pharmaceutical Inspection Co-operation Scheme โ€” South Africa is PIC/S member), cGMP 21 CFR Parts 210/211 (FDA), EU GMP EudraLex Volume 4, CE Machinery Directive 2006/42/EC, and 21 CFR Part 11 โ€” accepted by all major African pharmaceutical regulatory authorities and qualified for WHO Prequalification (PQ) tender participation.

African Market Coverage: HIJ has supplied 30+ DPP-260 machines to African pharmaceutical manufacturers across Nigeria, Egypt, Kenya, South Africa, Ethiopia, Morocco, Algeria, Ghana, Ivory Coast, Senegal, Tanzania, Uganda, Tunisia, and Mozambique. Total installations include generic drug manufacturers, contract manufacturers, antimalarial producers, ART/HIV drug manufacturers, and government pharmaceutical localization programs supporting African Continental Free Trade Area (AfCFTA) and African Union's Pharmaceutical Manufacturing Plan for Africa (PMPA).

Author: Authored by Forester Xiang, founder and chief engineer of HIJ Machinery, with 20+ years pharmaceutical machinery experience including 20+ on-site audits at African pharmaceutical facilities across Nigeria, Egypt, Kenya, South Africa, Ethiopia, and Morocco.

Source: HIJ Machinery (Wenzhou)
Website: https://hijpackingmachine.com
This page: https://hijpackingmachine.com/dpp-260-blister-machine-africa/
Contact: [email protected] | WhatsApp: +86 13868822120
Last updated: January 2026
References: AfCFTA (African Continental Free Trade Area), PMPA (Pharmaceutical Manufacturing Plan for Africa), AMA (African Medicines Agency Treaty), HS Code 8422.30 (packaging machinery).

Let's Design Your Production Line

Share your requirements and I'll personally craft a solution that maximizes your efficiency and profitability.